Regulus Therapeutics
RGLS
#9140
Rank
S$0.12 B
Marketcap
$1.87
Share price
1.45%
Change (1 day)
-41.50%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -S$54.71 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$39.3 Million a decrease over its 2022 earnings that were of -S$36.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$54.71 Million39.23%
2023 -S$39.3 Million6.51%
2022 -S$36.9 Million2.53%
2021 -S$35.98 Million93.59%
2020 -S$18.59 Million-15.41%
2019 -S$21.98 Million-64.46%
2018 -S$61.82 Million-33.26%
2017 -S$92.63 Million-13.98%
2016 -S$0.11 Billion44.77%
2015 -S$74.38 Million-1.63%
2014 -S$75.62 Million203.6%
2013 -S$24.91 Million8.65%
2012 -S$22.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$5.86 B-10,722.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$10.60 B-19,298.05%๐Ÿ‡ซ๐Ÿ‡ท France
S$2.54 B-4,707.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.92 B-25,319.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
-S$0.32 Billion 469.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.18 Billion 224.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$11.19 Billion 20,154.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion 184.40%๐Ÿ‡บ๐Ÿ‡ธ USA